Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone

Choroidal neovascularization (CNV) secondary to age related macular degeneration is among the leading causes of legal blindness in developed countries. Photodynamic therapy (PDT) with verteporfin induces CNV closure causing little damage to healthy tissue, but the need to re-treat may lead to low fi...

Full description

Saved in:
Bibliographic Details
Published in:Clinical ophthalmology (Auckland, N.Z.) N.Z.), 2008-03, Vol.2 (1), p.71-75
Main Authors: Ruiz-Moreno, José M, Montero, Javier A
Format: Article
Language:English
Subjects:
age related macular degeneration
choroidal neovascularization
Macular degeneration
Ophthalmology
Photodynamic therapy
Review
steroid
triamcinolone
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Choroidal neovascularization (CNV) secondary to age related macular degeneration is among the leading causes of legal blindness in developed countries. Photodynamic therapy (PDT) with verteporfin induces CNV closure causing little damage to healthy tissue, but the need to re-treat may lead to low final visual acuity at an unacceptable cost. The association of intravitreous triamcinolone or antiangiogenic drugs with PDT has been used in order to reduce these limitations of the therapy. The combination of PDT and intravitreous triamcinolone, its complications and outcome at one and two-year follow-up are discussed.
ISSN:1177-5467
1177-5483
1177-5483
DOI:10.2147/OPTH.S1643